137 related articles for article (PubMed ID: 22471869)
1. The Nun Study: risk factors for pathology and clinical-pathologic correlations.
Mortimer JA
Curr Alzheimer Res; 2012 Jul; 9(6):621-7. PubMed ID: 22471869
[TBL] [Abstract][Full Text] [Related]
2. Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study.
Riley KP; Snowdon DA; Desrosiers MF; Markesbery WR
Neurobiol Aging; 2005 Mar; 26(3):341-7. PubMed ID: 15639312
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study.
SantaCruz KS; Sonnen JA; Pezhouh MK; Desrosiers MF; Nelson PT; Tyas SL
J Neuropathol Exp Neurol; 2011 Oct; 70(10):832-40. PubMed ID: 21937909
[TBL] [Abstract][Full Text] [Related]
4. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
Snowdon DA; Greiner LH; Mortimer JA; Riley KP; Greiner PA; Markesbery WR
JAMA; 1997 Mar; 277(10):813-7. PubMed ID: 9052711
[TBL] [Abstract][Full Text] [Related]
5. Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study.
Snowdon DA; Greiner LH; Markesbery WR
Ann N Y Acad Sci; 2000 Apr; 903():34-8. PubMed ID: 10818486
[TBL] [Abstract][Full Text] [Related]
6. "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?
Abner EL; Kryscio RJ; Schmitt FA; Santacruz KS; Jicha GA; Lin Y; Neltner JM; Smith CD; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2011; 25(3):445-53. PubMed ID: 21471646
[TBL] [Abstract][Full Text] [Related]
7. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology.
Abner EL; Nelson PT; Kryscio RJ; Schmitt FA; Fardo DW; Woltjer RL; Cairns NJ; Yu L; Dodge HH; Xiong C; Masaki K; Tyas SL; Bennett DA; Schneider JA; Arvanitakis Z
Alzheimers Dement; 2016 Aug; 12(8):882-9. PubMed ID: 26812281
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.
Riley KP; Snowdon DA; Markesbery WR
Ann Neurol; 2002 May; 51(5):567-77. PubMed ID: 12112102
[TBL] [Abstract][Full Text] [Related]
9. Trajectories of physical function prior to death and brain neuropathology in a community-based cohort: the act study.
LaCroix AZ; Hubbard RA; Gray SL; Anderson ML; Crane PK; Sonnen JA; Zaslavsky O; Larson EB
BMC Geriatr; 2017 Nov; 17(1):258. PubMed ID: 29096630
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
11. Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study.
Mortimer JA; Gosche KM; Riley KP; Markesbery WR; Snowdon DA
Neurology; 2004 Feb; 62(3):428-32. PubMed ID: 14872025
[TBL] [Abstract][Full Text] [Related]
12. Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.
Hecht M; Krämer LM; von Arnim CAF; Otto M; Thal DR
Acta Neuropathol; 2018 May; 135(5):681-694. PubMed ID: 29574591
[TBL] [Abstract][Full Text] [Related]
13. Postmortem indices linking risk factors to cognition: results from the Religious Order Study and the Memory and Aging Project.
Bennett DA
Alzheimer Dis Assoc Disord; 2006; 20(3 Suppl 2):S63-8. PubMed ID: 16917198
[TBL] [Abstract][Full Text] [Related]
14. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
[TBL] [Abstract][Full Text] [Related]
15. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
16. Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.
Serrano-Pozo A; Qian J; Monsell SE; Frosch MP; Betensky RA; Hyman BT
J Neuropathol Exp Neurol; 2013 Dec; 72(12):1182-92. PubMed ID: 24226270
[TBL] [Abstract][Full Text] [Related]
17. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Study of Pathological Outcomes in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age and Brains for Dementia Research Cohorts.
Robinson AC; Chew-Graham S; Davidson YS; Horan MA; Roncaroli F; Minshull J; du Plessis D; Pal P; Payton A; Pendleton N; Mann DMA
J Alzheimers Dis; 2020; 73(2):619-632. PubMed ID: 31796669
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease.
Ramos-Miguel A; Sawada K; Jones AA; Thornton AE; Barr AM; Leurgans SE; Schneider JA; Bennett DA; Honer WG
Acta Neuropathol; 2017 Mar; 133(3):395-407. PubMed ID: 27866231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
